BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16035951)

  • 1. Human cytomegalovirus-specific CD4(+) T-cell clones recognize cross-reactive peptides from the immediate early 1 protein.
    Le Roy E; Davignon JL
    Viral Immunol; 2005; 18(2):391-6. PubMed ID: 16035951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of an epitope of the human cytomegalovirus protein IE1 recognized by a CD4+ T cell clone.
    Gautier N; Chavant E; Prieur E; Monsarrat B; Mazarguil H; Davrinche C; Gairin JE; Davignon JL
    Eur J Immunol; 1996 May; 26(5):1110-7. PubMed ID: 8647175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a conserved HLA-A2-restricted decapeptide from the IE1 protein (pUL123) of human cytomegalovirus.
    Frankenberg N; Pepperl-Klindworth S; Meyer RG; Plachter B
    Virology; 2002 Apr; 295(2):208-16. PubMed ID: 12033779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo stimulation and expansion of both CD4(+) and CD8(+) T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65.
    Vaz-Santiago J; Lulé J; Rohrlich P; Jacquier C; Gibert N; Le Roy E; Betbeder D; Davignon JL; Davrinche C
    J Virol; 2001 Sep; 75(17):7840-7. PubMed ID: 11483727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
    Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C
    Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of ocular-derived human alphaherpesvirus cross-reactive CD4 T cells.
    Ouwendijk WJ; Geluk A; Smits SL; Getu S; Osterhaus AD; Verjans GM
    J Immunol; 2014 Apr; 192(8):3730-9. PubMed ID: 24623134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of HLA-A*0201-restricted T cell responses by natural polymorphism in the IE1(315-324) epitope of human cytomegalovirus.
    Prod'homme V; Retière C; Imbert-Marcille BM; Bonneville M; Hallet MM
    J Immunol; 2003 Feb; 170(4):2030-6. PubMed ID: 12574373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of CD4+ T lymphocyte response to human cytomegalovirus nuclear IE1 protein through modifications of both size and cellular localization.
    Delmas S; Martin L; Baron M; Nelson JA; Streblow DN; Davignon JL
    J Immunol; 2005 Nov; 175(10):6812-9. PubMed ID: 16272338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-human cytomegalovirus activity of cytokines produced by CD4+ T-cell clones specifically activated by IE1 peptides in vitro.
    Davignon JL; Castanié P; Yorke JA; Gautier N; Clément D; Davrinche C
    J Virol; 1996 Apr; 70(4):2162-9. PubMed ID: 8642638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage cultures are susceptible to lytic productive infection by endothelial-cell-propagated human cytomegalovirus strains and present viral IE1 protein to CD4+ T cells despite late downregulation of MHC class II molecules.
    Sinzger C; Eberhardt K; Cavignac Y; Weinstock C; Kessler T; Jahn G; Davignon JL
    J Gen Virol; 2006 Jul; 87(Pt 7):1853-1862. PubMed ID: 16760387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactivity of HLA-B*1801-restricted T-lymphocyte clones with target cells expressing variants of the human cytomegalovirus 72kDa-IE1 protein.
    Prod'homme V; Retière C; Valtcheva R; Bonneville M; Hallet MM
    J Virol; 2003 Jun; 77(12):7139-42. PubMed ID: 12768035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine specificity of cellular immune responses in humans to human cytomegalovirus immediate-early 1 protein.
    Alp NJ; Allport TD; Van Zanten J; Rodgers B; Sissons JG; Borysiewicz LK
    J Virol; 1991 Sep; 65(9):4812-20. PubMed ID: 1714519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flavivirus-cross-reactive, HLA-DR15-restricted epitope on NS3 recognized by human CD4+ CD8- cytotoxic T lymphocyte clones.
    Kurane I; Okamoto Y; Dai LC; Zeng LL; Brinton MA; Ennis FA
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2243-9. PubMed ID: 7561761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of human cytomegalovirus immediate early protein IE1 in insect cells: splicing of RNA and recognition by CD4+ T-cell clones.
    Davrinche C; Pasquier C; Cerutti M; Serradell L; Clément D; Devauchelle G; Michelson S; Davignon JL
    Biochem Biophys Res Commun; 1993 Aug; 195(1):469-77. PubMed ID: 8395835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
    Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
    Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, pp150, and pp28 in healthy individuals: reevaluation of prevalence of IE1-specific CTLs.
    Gyulai Z; Endresz V; Burian K; Pincus S; Toldy J; Cox WI; Meric C; Plotkin S; Gönczöl E; Berencsi K
    J Infect Dis; 2000 May; 181(5):1537-46. PubMed ID: 10823751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and HLA-tetramer-validation of human CD4+ and CD8+ T cell responses against HCMV proteins IE1 and IE2.
    Braendstrup P; Mortensen BK; Justesen S; Osterby T; Rasmussen M; Hansen AM; Christiansen CB; Hansen MB; Nielsen M; Vindeløv L; Buus S; Stryhn A
    PLoS One; 2014; 9(4):e94892. PubMed ID: 24760079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the proliferative T cell response to human cytomegalovirus major immediate-early protein (IE1): phenotype, frequency and variability.
    Davignon JL; Clément D; Alriquet J; Michelson S; Davrinche C
    Scand J Immunol; 1995 Mar; 41(3):247-55. PubMed ID: 7871384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of transgenic HLA A*0201/Kb and HHD II mice to evaluate frequency of cytomegalovirus IE1-derived peptide usage in eliciting human CD8 cytokine response.
    Gallez-Hawkins G; Villacres MC; Li X; Sanborn MC; Lomeli NA; Zaia JA
    J Virol; 2003 Apr; 77(7):4457-62. PubMed ID: 12634406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refinement in the production and purification of recombinant HCMV IE1-pp65 protein for the generation of epitope-specific T cell immunity.
    Nguyen TH; Mifsud NA; Stewart LA; Rose MJ; Etto TL; Williamson NA; Purcell AW; Kotsimbos T; Schwarer AP
    Protein Expr Purif; 2008 Sep; 61(1):22-30. PubMed ID: 18539483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.